Background For more than a decade, guidelines have recommended a limited 3 months of anticoagulation for the treatment of provoked venous thromboembolism (VTE). How closely real‐world practice foll…
New research suggests that A-fib may be more prevalent, and more dangerous, in people under 65 than previously thought.
Bleeding is a well-recognized side effect of anticoagulant therapy, which is used to treat venous thromboembolism (VTE) in individuals of all ages, including those of…
Bleeding is a well-recognized side effect of anticoagulant therapy, which is used to treat venous thromboembolism (VTE) in individuals of all ages, including those of…
Background: As preferences for oral anticoagulation shift from warfarin to direct oral anticoagulants (DOACs), a new care management model is needed. A population approach leveraging…
Background: As preferences for oral anticoagulation shift from warfarin to direct oral anticoagulants (DOACs), a new care management model is needed. A population approach leveraging…
Balancing the safety and efficacy of antithrombotic agents in patients with gastrointestinal disorders is challenging because of the potential for interference with the absorption of…
This quality improvement intervention was associated with an acceleration of a preexisting decrease in aspirin use among patients taking warfarin for atrial fibrillation and/or venous…
ACC Emerging Faculty Leadership Academy Call for Nominations – Due January 2, 2024 The American College of Cardiology (ACC) is now accepting nominations for the…
Twenty years ago, beloved NBC journalist David Bloom passed away from a pulmonary embolism while embedded with American troops in Iraq. His widow Melanie joins…
Join us for an inspiring and heartfelt interview with Melanie Bloom, the beloved wife of the late global news correspondent, David Bloom. In this exclusive…
